by Dr Sunil Upadhyay – Malignant Pleural Mesothelioma (MPM) is of insidious onset and almost uniformly a fatal disease. Around 90% of the patients can be linked to… read more.
by Dr Sunil Upadhyay – Increased Met signalling in tumours can occur from increased levels of Hepatocyte Growth Factor (HGF), activating mutations within Met, and/or receptor over expression… read more.
by Dr Sunil Upadhyay – Advanced non-small cell carcinoma of the lung represents one of the major unmet needs for an effective and prolonged survival outcome. The majority… read more.
by Dr Sunil Upadhyay – Since the publication of the iPASS trial data, gefitinib has become the treatment of choice in EGFR mutation positive tumours. However, almost all… read more.
by Dr Sunil Upadhyay – At the recently held 14th World Conference on Lung Cancer in Amsterdam, on behalf of the investigators, the randomised phase III clinical trial… read more.
by Dr Sunil Upadhyay – A platinum doublet remains the current gold standard in the management of EGFR mutation negative, advanced non-small cell lung cancers. Pemetrexed is the… read more.
by Dr Sunil Upadhyay – The way we have defined cancer has not changed over centuries. Most of the lung cancers are associated with smoking. There is plenty… read more.
Foreward by Dr Sanjay Popat (pictured). The 14th Annual Scientific Meeting of the IASLC has now closed. Held in Amsterdam at the beginning of July 2011, the annual… read more.
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
